FFCP PHASE1:Mm9::chr14:103416344..103416380,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr14:103416344..103416380,-|id=chr14:103416344..103416380,-|ontology_enrichment_celltype=CL:0000624!2.75e-09!8;CL:0000815!4.39e-09!1;CL:0000792!4.39e-09!1;CL:0000355!1.05e-08!9;CL:0000791!2.56e-08!9;CL:0000789!2.56e-08!9;CL:0002420!2.56e-08!9;CL:0002419!2.56e-08!9;CL:0000790!2.56e-08!9;CL:0000084!6.62e-07!11;CL:0000827!6.62e-07!11|ontology_enrichment_celltype_v019_2=CL:0000355,4.60e-15,9|ontology_enrichment_disease=DOID:0060100!7.81e-25!3;DOID:4045!7.81e-25!3;DOID:0050686!9.15e-13!6|ontology_enrichment_disease_v019_2=DOID:0060100,2.45e-43,3;DOID:4045,2.45e-43,3;DOID:0050686,3.68e-22,6|ontology_enrichment_uberon=UBERON:0001134!1.05e-08!9;UBERON:0002036!1.05e-08!9;UBERON:0002385!1.05e-08!9;UBERON:0000486!1.05e-08!9;UBERON:0001015!1.05e-08!9;UBERON:0004290!1.05e-08!9;UBERON:0003082!1.05e-08!9;UBERON:0000383!6.86e-08!10;UBERON:0002329!3.21e-07!11;UBERON:0003077!3.21e-07!11;UBERON:0003059!3.21e-07!11;UBERON:0007282!3.21e-07!11;UBERON:0009618!3.21e-07!11;UBERON:0007285!3.21e-07!11|ontology_enrichment_uberon_v019_2=UBERON:0001134,4.60e-15,9;UBERON:0002036,4.60e-15,9;UBERON:0002385,4.60e-15,9;UBERON:0000486,4.60e-15,9;UBERON:0007503,4.60e-15,9;UBERON:0001015,4.60e-15,9;UBERON:0002329,4.60e-15,9;UBERON:0003082,4.60e-15,9;UBERON:0003059,4.60e-15,9;UBERON:0007282,4.60e-15,9;UBERON:0004290,4.60e-15,9;UBERON:0009618,4.60e-15,9;UBERON:0000383,1.22e-13,10;UBERON:0007524,1.80e-12,11;UBERON:0003077,1.80e-12,11;UBERON:0007285,1.80e-12,11|phase1_expression=0,0,0,0,0,0,0,0.258246646883153,0,0,0.171217968225505,0,0,0.0874204024189974,0,0,0.699561878128147,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.393012183581,7.0320181007142,6.28228492768558,46.4702875544501,34.1522742479223,13.5942898848723,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.702213187313235,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr14:103416344..103416380,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr14:103416344..103416380,- | |||
|description=CAGE_peak_at_chr14:103416344..103416380,- | |||
|id=chr14:103416344..103416380,- | |||
|ontology_enrichment_celltype=CL:0000624!2.75e-09!8;CL:0000815!4.39e-09!1;CL:0000792!4.39e-09!1;CL:0000355!1.05e-08!9;CL:0000791!2.56e-08!9;CL:0000789!2.56e-08!9;CL:0002420!2.56e-08!9;CL:0002419!2.56e-08!9;CL:0000790!2.56e-08!9;CL:0000084!6.62e-07!11;CL:0000827!6.62e-07!11 | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,4.60e-15,9 | |||
|ontology_enrichment_disease=DOID:0060100!7.81e-25!3;DOID:4045!7.81e-25!3;DOID:0050686!9.15e-13!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,2.45e-43,3;DOID:4045,2.45e-43,3;DOID:0050686,3.68e-22,6 | |||
|ontology_enrichment_uberon=UBERON:0001134!1.05e-08!9;UBERON:0002036!1.05e-08!9;UBERON:0002385!1.05e-08!9;UBERON:0000486!1.05e-08!9;UBERON:0001015!1.05e-08!9;UBERON:0004290!1.05e-08!9;UBERON:0003082!1.05e-08!9;UBERON:0000383!6.86e-08!10;UBERON:0002329!3.21e-07!11;UBERON:0003077!3.21e-07!11;UBERON:0003059!3.21e-07!11;UBERON:0007282!3.21e-07!11;UBERON:0009618!3.21e-07!11;UBERON:0007285!3.21e-07!11 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,4.60e-15,9;UBERON:0002036,4.60e-15,9;UBERON:0002385,4.60e-15,9;UBERON:0000486,4.60e-15,9;UBERON:0007503,4.60e-15,9;UBERON:0001015,4.60e-15,9;UBERON:0002329,4.60e-15,9;UBERON:0003082,4.60e-15,9;UBERON:0003059,4.60e-15,9;UBERON:0007282,4.60e-15,9;UBERON:0004290,4.60e-15,9;UBERON:0009618,4.60e-15,9;UBERON:0000383,1.22e-13,10;UBERON:0007524,1.80e-12,11;UBERON:0003077,1.80e-12,11;UBERON:0007285,1.80e-12,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0.258246646883153,0,0,0.171217968225505,0,0,0.0874204024189974,0,0,0.699561878128147,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.393012183581,7.0320181007142,6.28228492768558,46.4702875544501,34.1522742479223,13.5942898848723,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.702213187313235,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr14:103416344..103416380,- | |||
}} |
Latest revision as of 21:58, 3 August 2015
Short description: | p@chr14:103416344..103416380, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr14:103416344..103416380, - |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 4.60e-15 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 4.60e-15 | 9 |
striated muscle tissue | 4.60e-15 | 9 |
muscle tissue | 4.60e-15 | 9 |
multilaminar epithelium | 4.60e-15 | 9 |
epithelial vesicle | 4.60e-15 | 9 |
musculature | 4.60e-15 | 9 |
somite | 4.60e-15 | 9 |
myotome | 4.60e-15 | 9 |
presomitic mesoderm | 4.60e-15 | 9 |
presumptive segmental plate | 4.60e-15 | 9 |
dermomyotome | 4.60e-15 | 9 |
trunk paraxial mesoderm | 4.60e-15 | 9 |
musculature of body | 1.22e-13 | 10 |
dense mesenchyme tissue | 1.80e-12 | 11 |
paraxial mesoderm | 1.80e-12 | 11 |
presumptive paraxial mesoderm | 1.80e-12 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 2.45e-43 | 3 |
muscle cancer | 2.45e-43 | 3 |
organ system cancer | 3.68e-22 | 6 |